Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for C20 ketopregnane alkaloids offering cost reduction and scalable manufacturing for pharmaceutical intermediates and anti-tumor drug development.
Patent CN117327010A reveals a novel Pd-catalyzed C-H amination route for high-purity 3-tert-butylaminoacrylamide derivatives, offering significant supply chain and cost advantages.
Patent CN1662525A reveals a novel route for 1,2,4-triazolylmethyl-oxiranes, offering superior regioselectivity and simplified purification for agrochemical manufacturing.
Patent CN109912426B reveals a cost-effective route for (2R,5R)-1,6-diphenyl-2,5-hexanediamine. Discover scalable manufacturing solutions for HIV drug intermediates.
Patent CN110818774A details a novel synthesis for a 40000x sweetener. Discover cost-effective manufacturing strategies and supply chain advantages for food additives.
Novel synthetic route for Elacestrant improves yield and purity while reducing hazardous reagent use for reliable supply chain continuity.
Novel enzymatic synthesis route ensures high purity and yield for HIV integrase inhibitor intermediates, offering significant supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Advanced synthesis of triarylamine-substituted terpyridine ruthenium complexes via Pd-catalyzed coupling for high-performance molecular electronics applications.
Patent CN103073483A reveals a safe, high-yield route for Mepivacaine using formic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN113773206B reveals metal-free Butenafine synthesis using CO2. This method offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel deamination reduction route for 1H-tetrazole-1-acetic acid offers high purity >97% and safer processing for antibiotic intermediates.
Patent CN102978251A reveals a low-cost enzymatic route for L-tert-leucine. Achieve >99% optical purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Patent CN101935294B reveals diazotization deamination recycling C acid by-products, reducing waste and enhancing supply chain reliability for dye manufacturers.
Patent CN117024314B details a safer synthesis route for Tamsulosin intermediates, offering high purity and reduced waste for reliable supply chain integration.
Novel radical bifunctionalization of naphthoquinones using NIS. High yield, mild conditions. Reliable supplier for API intermediates.
Patent CN104892443B reveals a high-yield chiral synthesis route for (s)-3-hydroxyadamantane glycine, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112930348A details an enzymatic route for Safraninib, improving yield and reducing waste compared to chiral resolution methods.
Patent CN110156608B reveals a novel catalytic route for p-chlorophenethylamine, offering safer processing and high purity for reliable pharmaceutical intermediate suppliers.
Novel preparation method for Maraviroc derivatives using gamma-position azide compounds. Offers mild conditions, high purity, and cost-effective scale-up for API manufacturing.